Related by context. Frequent words. (Click for all words.) 62 FDA Complete Response 62 FDA Accepts 61 Application BLA 59 R sorafenib tablets 59 refractory chronic lymphocytic 59 Complete Response 59 QNEXA 59 supplemental Biologics License Application 58 Complete Response letter 58 Complete Response Letter 58 Panzem R 58 editor letters@smdailyjournal.com 58 Phenoptin 58 Act PDUFA date 57 FDA approvable letter 57 ELADUR 57 Biologics License Application BLA 57 Marketing Authorization Application 57 approvability 57 Entereg R 56 Company Nasdaq PRGO 56 Vytorin combines 56 TranSwitch indebtedness 56 Application MAA 56 By Justin Berka 56 SILENOR TM 56 Pivotal Phase III 55 Pirfenidone 55 document.getElementById root root 55 ANDA containing 55 ZALBIN 55 letters@mndaily.com 55 alogliptin 55 Fablyn 55 Biologics License Application 55 Marketing Authorization Application MAA 55 Patient Enrollment 55 alvimopan 55 submitted Biologics License 55 QAB# 55 Argatroban 55 application sNDA 55 Nasdaq BDSI 55 Inc. Nasdaq IMGN 54 Amyvid 54 Exelbine 54 newsroom@kristv.com 54 pseudobulbar affect PBA 54 Reader Comment Guidelines 54 CHMP recommendation 54 Zalbin 54 Ambrisentan 54 Kuvan R 54 ezogabine 54 peginesatide 54 Ixempra 54 Transcept Pharmaceuticals 54 sBLA 54 TRANSDUR Sufentanil 54 bifeprunox 54 BLA submission 53 Initiate Phase 53 NASDAQ SHPGY 53 liprotamase 53 Daytrana TM 53 Only registred users 53 NASDAQ DYAX 53 Exalgo 53 anidulafungin 53 Cladribine 53 Nasdaq AMLN 53 Nasdaq VRTX 53 Vimovo 53 By Miranda Hitti 53 See BioWorld Today 53 By Thomas Zocher 53 exemption IDE 53 Vilazodone 53 Solzira 52 European Medicines Evaluation 52 NVA# 52 dalbavancin 52 Drug Application 52 FIRAZYR 52 Pivotal Phase 52 JZP 6 52 Gestiva 52 BENLYSTA 52 iloperidone 52 prGCD 52 Omigard 52 elotuzumab 52 registrational trial 52 Rhucin ® 52 Rotarix R 52 Inc. NASDAQ HGSI 52 Xinlay 52 Note Movie showtimes 52 PDUFA date 52 BEMA Buprenorphine 52 image above.Error No